Abstract
The purpose of this report was to develop solvent-free biodegradable scleral plugs for vancomycin, amikacin and dexamethasone delivery for endophthalmitis treatment. To fabricate a biodegradable plug, polylactide-polyglycolide copolymers were pre-mixed with the drugs. The mixture was then compression molded and sintered to form a scleral plug of 1.4 mm in diameter. An elution method was utilized to characterize the in vitro release characteristics of the antibiotics and the steroids over a 14-day period. The HPLC analysis and bacterial inhibition test showed that biodegradable scleral plugs released a high concentration resulting in significant activity of vancomycin and amikacin (well above the minimum inhibition concentrations) and dexamethasone in vitro, for the period of time needed to treat intraocular infection. A bacterial inhibition test was carried out to determine the relative activity of the released antibiotics. The activities of the eluted vancomycin and amikacin ranged from 69% to 89% and from 66% to 88%, respectively. In addition, the experimental result suggests that one will be able to reduce the drug release rate and prolong the total release period of the plugs by adopting a lower antibiotic/steroid to polymer ratio, increasing the sintering temperature, or increasing the compression pressures.
Original language | English |
---|---|
Pages (from-to) | 75-80 |
Number of pages | 6 |
Journal | International Journal of Pharmaceutics |
Volume | 370 |
Issue number | 1-2 |
DOIs | |
State | Published - 31 03 2009 |
Keywords
- Amikacin
- Biodegradable scleral plugs
- Dexamethasone
- Endophthalmitis
- In vitro elution
- Polylactide-polyglycolide
- Release characteristics
- Vancomycin